Association of Tripartite Motif Containing 11 rs564309 with Tau Pathology in Progressive Supranuclear Palsy

Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology

(2019) Michael G. Heckman et al.   JAMA Neurology

Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy

(2019) Farwa Ali et al.   MOVEMENT DISORDERS

The genetic and clinico‐pathological profile of early‐onset progressive supranuclear palsy

(2019) Edwin Jabbari et al.   MOVEMENT DISORDERS

Variation at the TRIM 11 Locus Modifies Progressive Supranuclear Palsy Phenotype

(2018) Edwin Jabbari et al.   ANNALS OF NEUROLOGY

APOE ε2 is associated with increased tau pathology in primary tauopathy

(2018) Na Zhao et al.   Nature Communications

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

(2017) Günter U. Höglinger et al.   MOVEMENT DISORDERS

Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

(2015) Melissa E. Murray et al.   BRAIN

Neuropathology of variants of progressive supranuclear palsy

(2010) Dennis W Dickson et al.   CURRENT OPINION IN NEUROLOGY